
Around 6,500 people are diagnosed with myeloma in the UK each year

The company has been given manufacturing and marketing authorisation for the therapy

The platform will passively collect data to understand treatment responses in everyday life

The company also received a grant from the Michael J. Fox Foundation and Parkinson’s UK

The partnership will provide financial support and strengthen early detection and intervention efforts

The new ‘Brain Health Matters’ campaign urges the public to prioritise brain health

The US-based company develops light-based therapies for neurodegenerative conditions

More than 55 million people worldwide are currently living with the neurodegenerative disease

An estimated 982,000 people in the UK are currently living with the neurodegenerative disease

The alliance is aimed at developing treatments for Parkinson's and another neurodegeneration indication

The neurodegenerative disorder accounts for up to 75% of the 982,000 dementia cases in the UK

Frontotemporal dementia accounts for less than one in 30 cases of the neurodegenerative disorder